Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cosmo Pharmaceuticals NV

www.cosmopharma.com

Latest From Cosmo Pharmaceuticals NV

Deal Watch: Gilead Hopes Glympse’s Synthetic Biomarkers Can Optimize NASH Trials

Gilead partners with Glympse to optimize NASH trials, while Ironwood will work with Pear on digital therapies for GI disorders. An alliance between Leo and Ubiquigent yields an option agreement around two novel compounds.

Deals Business Strategies

BIO-Europe Spring 2019: Finally, Paion Teeters On Cusp Of Commercialization

Wolfgang Söhngen, CEO and founder of Paion, discusses the company’s anesthetic/sedative, remimazolam, which has been filed for approval in China, Japan and the US, as well as broader business strategies.

Commercial Business Strategies

Cassiopea Hails Breezula's 'Good Hair Day' And Plans FDA Talks On Phase III

Italy-based Cassiopea says “very positive results” from Breezula's 12-month Phase II alopecia trial support progressing  it to Phase III, particularly given the clean safety profile.

Clinical Trials Companies

US FDA’s Record Tally Of NMEs Outpaces Ability To Issue Press Releases

US FDA may have set record for new drug approvals during 2018, but agency actually issued press releases highlighting approvals less often than it has in the past.
Approvals FDA
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
    • Nutraceuticals
  • Therapeutic Areas
  • Gastrointestinal
  • Alias(es)
  • Cosmo Pharmaceuticals SPA
  • Cosmo Pharmaceuticals SA
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Ireland
  • Parent & Subsidiaries
  • Cosmo Pharmaceuticals NV
  • Senior Management
  • Alessandro Della Chà, CEO
    Niall Donnelly, CFO
    Luigi Moro, PhD, CSO
    Massimo Pedrani, Head, Generics Bus. Dev.
    Giuseppe Cipriano, COO
  • Contact Info
  • Cosmo Pharmaceuticals NV
    Phone: (39) 1 817 0370
    Sir John Rogerson’s Quay
    Riverside II
    Dublin 2,
    Ireland
UsernamePublicRestriction

Register